The correlation we report between clinical progression-free survival and overexpression of p53, and its relationship to other clinical factors of importance in astrocytoma tumour progression, suggests that quantitative increases in expression of overall p53 protein are biologically significant in the neoplastic process of astrocytic tumours. This evidence concerns the gene TP53 and neoplasm.